CD44 and adenocarcinoma: For instance, the current data suggested that CD44 rs187115-positive adenocarcinoma patients who had surgical resection were less likely to have a good oncologic outcome after surgical treatment even at a resectable stage, and therefore, should be considered for alternative chemotherapy or radiotherapy protocols [28].